Document:

Exhibit 10.1

 

 

2022 EQUITY INCENTIVE PLAN

 

LONGWEN GROUP CORP.

 

1.           Purpose.
The purpose of the 2022 Equity Incentive Plan (the “2022 Plan”) of Longwen Group Corp. (the “Company”) is to increase
stockholder value and to advance the interests of the Company by furnishing a variety of economic incentives (“Incentives”)
designed to attract, retain and motivate employees, certain key consultants and directors of the Company. Incentives may consist of opportunities
to purchase or receive shares of Common Stock, $0.0001 par value, of the Company (“Common Stock”) on terms determined under
this 2022 Plan. The 2022 Plan was adopted by the Board on November 7, 2022.

 

2.           Administration.
The 2022 Plan shall be administered by the Board of Directors or by a stock option or compensation committee (the “Committee”)
of the Board of Directors of the Company. The Committee shall consist of not less than two directors of the Company and shall be appointed
from time to time by the board of directors of the Company. Each member of the Committee shall be (i) a “non-employee director”
within the meaning of Rule 16b-3 of the Securities Exchange Act of 1934 (including the regulations promulgated thereunder, the “1934
Act”) (a “Non-Employee Director”), and (ii) shall be an “outside director” within the meaning of Section
162(m) under the Internal Revenue Code of 1986, as amended (the “Code”) and the regulations promulgated thereunder. The Committee
shall have complete authority to award Incentives under the 2022 Plan, to interpret the 2022 Plan, and to make any other determination
which it believes necessary and advisable for the proper administration of the 2022 Plan. The Committee’s decisions and matters
relating to the 2022 Plan shall be final and conclusive on the Company and its participants. If at any time there is no stock option or
compensation committee, the term “Committee”, as used in the 2022 Plan, shall refer to the Board of Directors.

 

3.           Eligible
Participants. Officers of the Company, employees of the Company or its subsidiaries, members of the Board of Directors, and consultants
or other independent contractors who provide services to the Company or its subsidiaries shall be eligible to receive Incentives under
the 2022 Plan when designated by the Committee. Participants may be designated individually or by groups or categories (for example, by
pay grade) as the Committee deems appropriate. Participation by officers of the Company or its subsidiaries and any performance objectives
relating to such officers must be approved by the Committee. Participation by others and any performance objectives relating to others
may be approved by groups or categories (for example, by pay grade) and authority to designate participants who are not officers and to
set or modify such targets may be delegated. Participation is entirely at the discretion of the Committee and is not automatically continued
after an initial period of participation.

 

4.           Types
of Incentives. Incentives under the 2022 Plan may be granted in any one or a combination of the following forms: (a) incentive stock
options and non-statutory stock options (Section 6); (b) stock appreciation rights (“SARs”) (Section 7); (c) stock awards
(Section 8); (d) restricted stock (Section 8); and (e) performance shares (Section 9).

 

5.           Shares
Subject to the 2022 Plan.

 

5.1         Number
of Shares. Subject to adjustment as provided in Section 10.6, the number of shares of Common Stock which may be issued under the 2022
Plan shall not exceed 10,000,000 shares of Common Stock. Shares of Common Stock that are issued under the 2022 Plan or are subject
to outstanding Incentives will be applied to reduce the maximum number of shares of Common Stock remaining available for issuance under
the 2022 Plan. Shares of Common Stock subject to a participant’s exercise of either an option or a SAR, but not both (a “tandem
SAR”), shall be counted only once. 

 

5.2         Cancellation.
To the extent that cash in lieu of shares of Common Stock is delivered upon the exercise of a SAR pursuant to Section 7.4, the Company
shall be deemed, for purposes of applying the limitation on the number of shares, to have issued the greater of the number of shares of
Common Stock which it was entitled to issue upon such exercise or on the exercise of any related option. In the event that a stock option
or SAR granted hereunder expires or is terminated or canceled unexercised as to any shares of Common Stock, such shares may again be issued
under the 2022 Plan either pursuant to stock options, SARs or otherwise. In the event that shares of Common Stock are issued as restricted
stock or pursuant to a stock award and thereafter are forfeited or reacquired by the Company pursuant to rights reserved upon issuance
thereof, such forfeited and reacquired shares may again be issued under the 2022 Plan, either as restricted stock, pursuant to stock awards
or otherwise.

 

5.3         Type
of Common Stock. Common Stock issued under the 2022 Plan in connection with stock options, SARs, performance shares, restricted stock
or stock awards, may be authorized and unissued shares or treasury stock, as designated by the Committee.

 

  
     

     

    
 

6.           Stock
Options. A stock option is a right to purchase shares of Common Stock from the Company at a specified price. Each stock option granted
by the Committee under this 2022 Plan shall be subject to the following terms and conditions:

 

6.1         Price.
The option price per share shall be determined by the Committee, subject to adjustment under Section 10.6, and except for non-qualified
stock options, shall never be less than the greater of (1) the Fair Market Value of the Common Stock on the date of grant of the option
or (2) the par value of the Common Stock. Other than in connection with a change in the Company’s capitalization (as described in
Section 10.6), a Stock Option may not be re-priced without Shareholder approval (including canceling previously awarded Stock Options
and re-granting them with a lower exercise price).

 

6.2        Number.
The number of shares of Common Stock subject to the option shall be determined by the Committee, subject to adjustment as provided in
Section 10.6. In the case of a tandem SAR, the number of shares of Common Stock available upon exercise of the participant’s stock
option shall be reduced to reflect any tandem SARs already exercised by the participant.

 

6.3         Duration
and Time for Exercise. Subject to earlier termination as provided in Section 6.5 and/or Section 10.4, the term of each stock option
shall be determined by the Committee but shall not exceed ten years from the date of grant. Each stock option shall become exercisable
at such time or times during its term as shall be determined by the Committee at the time of grant. The Committee may accelerate the exercisability
of any stock option. Subject to the foregoing and with the approval of the Committee, all or any part of the shares of Common Stock with
respect to which the right to purchase has accrued may be purchased by the Company at the time of such accrual or at any time or times
thereafter during the term of the option, provided that the purchase price may not exceed the Fair Market Value of the shares at the time
of purchase.

 

6.4         Manner
of Exercise. A stock option may be exercised, in whole or in part, by giving written notice to the Company, specifying the number
of shares of Common Stock to be purchased and accompanied by the full purchase price for such shares. The option price shall be payable
(a) in United States dollars upon exercise of the option and may be paid by cash, uncertified or certified check or bank draft; (b) at
the discretion of the Committee, by delivery of shares of Common Stock in payment of all or any part of the option price, which shares
shall be valued for this purpose at the Fair Market Value on the date such option is exercised; or (c) at the discretion of the Committee,
by instructing the Company to withhold from the shares of Common Stock issuable upon exercise of the stock option shares of Common Stock
in payment of all or any part of the exercise price and/or any related withholding tax obligations, which shares shall be valued for this
purpose at Fair Market Value or in such other manner as may be authorized from time to time by the Committee. Stock options will not be
granted under the 2022 Plan in consideration for and shall not be conditioned upon the delivery of shares of Common Stock to the Company
in payment of the exercise price and/or tax withholding obligation under any other stock option or SAR of the participant. Prior to the
issuance of shares of Common Stock upon the exercise of a stock option, a participant shall have no rights as a stockholder.

  

6.5         Incentive
Stock Options. Notwithstanding anything in the 2022 Plan to the contrary, the following additional provisions shall apply to the grant
of stock options which are intended to qualify as Incentive Stock Options (as such term is defined in Section 422 of the Code):

 

	 	(a)	Incentive Stock Options may only be granted to employees of the Company and may not remain exercisable later than three months after the participant’s termination of employment (or such other period of time provided in Section 422 of the Code).  Notwithstanding the foregoing, the Committee may provide that a stock option may be exercisable for a period of time longer than three months after the participant’s termination of employment as long as it is not beyond the original term of the stock option grant; however, any amendment to a stock option originally issued as an Incentive Stock Option to provide exercise later than three months after the participant’s termination of employment will cause the stock option to no longer be qualified as an Incentive Stock Option if such stock option is exercised later than three months after the participant’s termination of employment.

 

	 	(b)	The aggregate Fair Market Value (determined as of the time the option is granted) of the shares of Common Stock with respect to which Incentive Stock Options are exercisable for the first time by any participant during any calendar year (under all of the Company’s plans) shall not exceed $200,000. The determination will be made by taking incentive stock options into account in the order in which they were granted. If such excess only applies to a portion of an Incentive Stock Option, the Committee, in its discretion, will designate which shares will be treated as shares to be acquired upon exercise of an Incentive Stock Option.

 

  
     

     

    
	 	(c)	Any Incentive Stock Option certificate authorized under the 2022 Plan shall contain such other provisions as the Committee shall deem advisable, but shall in all events be consistent with and contain all provisions required in order to qualify the options as Incentive Stock Options.

 

	 	(d)	All Incentive Stock Options must be granted within ten years from the earlier of the date on which this 2022 Plan was adopted by Board of Directors or the date this 2022 Plan was approved by the stockholders.

 

	 	(e)	Unless sooner exercised, all Incentive Stock Options shall expire no later than 10 years after the date of grant.

  

	 	(f)	If Incentive Stock Options are granted to any participant who, at the time such option is granted, would own (within the meaning of Section 422 of the Code) stock possessing more than 10% of the total combined voting power of all classes of stock of the employer corporation or of its parent or subsidiary corporation, (i) the option price for such Incentive Stock Options shall be not less than 110% of the Fair Market Value of the Common Stock subject to the option on the date of grant and (ii) such Incentive Stock Options shall expire no later than five years after the date of grant.

 

	 	(g)	An Incentive Stock Option must not be transferable by the participant other than by will or the laws of descent and distribution and must be exercisable during the individual’s lifetime only by the individual, in accordance with Treasury Regulation 1.422-2(a)(2)(v).

 

7.           Stock
Appreciation Rights. A SAR is a right to receive, without payment to the Company, a number of shares of Common Stock, cash or any
combination thereof, the amount of which is determined pursuant to the formula set forth in Section 7.4. A tandem SAR may be granted (a)
with respect to any nonqualified stock option granted under this 2022 Plan, concurrently with the grant of such stock option (as to all
or any portion of the shares of Common Stock subject to the nonqualified stock option), or (b) alone, without reference to any related
stock option (a non-tandem SAR). Each SAR granted by the Committee under this 2022 Plan shall be subject to the following terms and conditions:

 

7.1         Number.
Each SAR granted to any participant shall relate to such number of shares of Common Stock as shall be determined by the Committee, subject
to the limitations in Section 6.2 and subject to adjustment as provided in Section 10.6. In the case of a tandem SAR granted with respect
to a nonqualified stock option, the number of shares of Common Stock subject to the SAR shall be reduced to reflect any nonqualified options
already exercised by the participant. SARs shall not be granted in tandem with Incentive Stock Options.

 

7.2         Duration.
Subject to earlier termination as provided in Section 10.4, the term of each SAR shall be determined by the Committee but shall not exceed
ten years and one day from the date of grant. Unless otherwise provided by the Committee, each SAR shall become exercisable at such time
or times, to such extent and upon such conditions as the stock option, if any, to which it relates is exercisable. The Committee may in
its discretion accelerate the exercisability of any SAR.

 

7.3         Exercise.
A SAR may be exercised, in whole or in part, by giving written notice to the Company, specifying the number of SARs which the holder wishes
to exercise. Upon receipt of such written notice, the Company shall, as soon as practicable and in any event before the fifteenth day
of the third month following the end of the Company’s fiscal year, deliver to the exercising holder certificates for the shares
of Common Stock or cash or both, as determined by the Committee, to which the holder is entitled pursuant to Section 7.4.

 

7.4         Payment.
Subject to the right of the Committee to deliver cash in lieu of shares of Common Stock (which, as it pertains to officers and directors
of the Company, shall comply with all requirements of the 1934 Act), the number of shares of Common Stock which shall be issuable upon
the exercise of a SAR shall be determined by dividing:

 

	 	(a)	the number of shares of Common Stock as to which the SAR is exercised multiplied by the amount of the appreciation in such shares (for this purpose, the “appreciation” shall be the amount by which the Fair Market Value of the shares of Common Stock subject to the SAR on the exercise date exceeds the Fair Market Value of the shares of Common Stock at the time of grant, subject to adjustment under Section 10.6); by

 

	 	(b)	the Fair Market Value of a share of Common Stock on the exercise date.

 

  
     

     

    
In lieu
of issuing shares of Common Stock upon the exercise of a SAR, the Committee may elect to pay the holder of the SAR cash equal to the Fair
Market Value on the exercise date of any or all of the shares which would otherwise be issuable. No fractional shares of Common Stock
shall be issued upon the exercise of a SAR; instead, the holder of the SAR shall be entitled to receive a cash adjustment equal to the
same fraction of the Fair Market Value of a share of Common Stock on the exercise date or to purchase the portion necessary to make a
whole share at its Fair Market Value on the date of exercise. Other than in connection with a change in the Company’s capitalization
(as described in Section 10.6), a SAR may not be re-priced without Shareholder approval (including canceling previously awarded SARs and
re-granting them at a time when the Fair Market Value of the shares of Common Stock is lower). SARs will not be granted under the 2022
Plan in consideration for and shall not be conditioned upon the delivery of shares of Common Stock to the Company in payment of the exercise
price and/or tax withholding obligation under any other stock option or SAR of the participant.

 

8.           Stock
Awards and Restricted Stock. A stock award consists of the transfer by the Company to a participant of shares of Common Stock, without
other payment therefor, as additional compensation for services to the Company. A share of restricted stock consists of shares of Common
Stock which are sold or transferred by the Company to a participant at a price determined by the Committee (which price shall be at least
equal to the minimum price required by applicable law for the issuance of a share of Common Stock) and subject to restrictions on their
sale or other transfer by the participant. The transfer of Common Stock pursuant to stock awards and the transfer and sale of restricted
stock shall be subject to the following terms and conditions: 

 

8.1         Number
of Shares. The number of shares to be transferred or sold by the Company to a participant pursuant to a stock award or as restricted
stock shall be determined by the Committee.

 

8.2         Sale
Price. The Committee shall determine the price, if any, at which shares of restricted stock shall be sold to a participant, which
may vary from time to time and among participants and which may be below the Fair Market Value of such shares of Common Stock at the date
of sale.

 

8.3          Restrictions.
All shares of restricted stock transferred or sold hereunder shall be subject to such restrictions as the Committee may determine, including,
without limitation any or all of the following:

 

	 	(a)	a prohibition against the sale, transfer, pledge or other encumbrance of the shares of restricted stock, such prohibition to lapse at such time or times as the Committee shall determine (whether in annual or more frequent installments, at the time of the death, disability or retirement of the holder of such shares, or otherwise);

 

	 	(b)	a requirement that the holder of shares of restricted stock forfeit, or (in the case of shares sold to a participant) resell back to the Company at his or her cost, all or a part of such shares in the event of termination of his or her employment or consulting engagement during any period in which such shares are subject to restrictions;

 

	 	(c)	such other conditions or restrictions as the Committee may deem advisable.

 

8.4         Escrow.
In order to enforce the restrictions imposed by the Committee pursuant to Section 8.3, the participant receiving restricted stock shall
enter into an agreement with the Company setting forth the conditions of the grant. Shares of restricted stock shall be registered in
the name of the participant and deposited, together with a stock power endorsed in blank, with the Company. Each such certificate shall
bear a legend in substantially the following form:

 

The transferability
of this certificate and the shares of Common Stock represented by it are subject to the terms and conditions (including conditions of
forfeiture) contained in the 2022 Plan, and an agreement entered into between the registered owner and the Company. A copy of the 2022
Plan and the agreement is on file in the office of the secretary of the Company.

 

8.5         End
of Restrictions. Subject to Section 10.5, at the end of any time period during which the shares of restricted stock are subject to
forfeiture and restrictions on transfer, such shares will be delivered free of all restrictions to the participant or to the participant’s
legal representative, beneficiary or heir.

 

8.6         Stockholder.
Subject to the terms and conditions of the 2022 Plan, each participant receiving restricted stock shall have all the rights of a stockholder
with respect to shares of stock during any period in which such shares are subject to forfeiture and restrictions on transfer, including
without limitation, the right to vote such shares. Dividends paid in cash or property other than Common Stock with respect to shares of
restricted stock shall be paid to the participant currently.

 

9.            Performance
Shares. A performance share consists of an award which shall be paid in shares of Common Stock, as described below. The grant of performance
share shall be subject to such terms and conditions as the Committee deems appropriate, including the following: 

 

  
     

     

    
9.1         Performance
Objectives. Each performance share will be subject to performance objectives for the Company or one of its operating units to be
achieved by the end of a specified period. The number of performance shares granted shall be determined by the Committee and may be subject
to such terms and conditions, as the Committee shall determine. If the performance objectives are achieved, each participant will be
paid in shares of Common Stock or cash. If such objectives are not met, each grant of performance shares may provide for lesser payments
in accordance with formulas established in the award.

9.2         Not
Stockholder. The grant of performance shares to a participant shall not create any rights in such participant as a stockholder of
the Company, until the payment of shares of Common Stock with respect to an award.

 

9.3         No
Adjustments. No adjustment shall be made in performance shares granted on account of cash dividends which may be paid or other rights
which may be issued to the holders of Common Stock prior to the end of any period for which performance objectives were established.

 

9.4         Expiration
of Performance Share. If any participant’s employment or consulting engagement with the Company is terminated for any reason
other than normal retirement, death or disability prior to the achievement of the participant’s stated performance objectives, all
the participant’s rights on the performance shares shall expire and terminate unless otherwise determined by the Committee. In the
event of termination of employment or consulting by reason of death, disability, or normal retirement, the Committee, in its own discretion
may determine what portions, if any, of the performance shares should be paid to the participant.

 

10.         General.

 

10.1       Effective
Date. The 2022 Plan will become effective on November 7, 2022.

 

10.2       Duration.
The 2022 Plan shall remain in effect until all Incentives granted under the 2022 Plan have either been satisfied by the issuance of shares
of Common Stock or the payment of cash or been terminated under the terms of the 2022 Plan and all restrictions imposed on shares of Common
Stock in connection with their issuance under the 2022 Plan have lapsed. No Incentives may be granted under the 2022 Plan after the tenth
anniversary of the Effective Date.

 

10.3       Non-transferability
of Incentives. No stock option, SAR or performance award may be transferred, pledged or assigned by the holder thereof (except, in
the event of the holder’s death, by will or the laws of descent and distribution to the limited extent provided in the 2022 Plan
or the Incentive Award), or pursuant to a qualified domestic relations order as defined by the Code or Title I of the Employee Retirement
Income Security Act, or the rules thereunder, and the Company shall not be required to recognize any attempted assignment of such rights
by any participant. Notwithstanding the preceding sentence, non-qualified stock options may be transferred by the holder thereof to Employee’s
spouse, children, grandchildren or parents (collectively, the “Family Members”), to trusts for the benefit of Family Members,
to partnerships or limited liability companies in which Family Members are the only partners or shareholders, or to entities exempt from
federal income taxation pursuant to Section 501(c)(3) of the Internal Revenue Code of 1986, as amended. During a participant’s lifetime,
a stock option may be exercised only by him or her, by his or her guardian or legal representative or by the transferees permitted by
the preceding sentence. Incentive Stock Options shall be subject to the further restrictions on transfer set forth in Section 6.5.

 

 

10.4       Effect
of Termination or Death. In the event that a participant ceases to be an employee of or consultant to the Company for any reason,
including death or disability, any Incentives may be exercised only as their terms may permit or shall expire at such times as may be
determined by the Committee as set forth in the 2022 Plan or the Incentive Award agreement. 

 

10.5       Additional
Condition. Notwithstanding anything in this 2022 Plan to the contrary: (a) the Company may, if it shall determine it necessary or
desirable for any reason, at the time of award of any Incentive or the issuance of any shares of Common Stock pursuant to any Incentive,
require the recipient of the Incentive, as a condition to the receipt thereof or to the receipt of shares of Common Stock issued pursuant
thereto, to deliver to the Company a written representation of present intention to acquire the Incentive or the shares of Common Stock
issued pursuant thereto for his or her own account for investment and not for distribution; and (b) if at any time the Company further
determines, in its sole discretion, that the listing, registration or qualification (or any updating of any such document) of any Incentive
or the shares of Common Stock issuable pursuant thereto is necessary on any securities exchange or under any federal or state securities
or blue sky law, or that the consent or approval of any governmental regulatory body is necessary or desirable as a condition of, or in
connection with the award of any Incentive, the issuance of shares of Common Stock pursuant thereto, or the removal of any restrictions
imposed on such shares, such Incentive shall not be awarded or such shares of Common Stock shall not be issued or such restrictions shall
not be removed, as the case may be, in whole or in part, unless such listing, registration, qualification, consent or approval shall have
been effected or obtained free of any conditions not acceptable to the Company.

 

  
     

     

    
10.6       Adjustment.
In the event of any recapitalization, stock dividend, stock split, combination of shares or other change in the Common Stock, the number
of shares of Common Stock then subject to the 2022 Plan, including shares subject to restrictions, options or achievements of performance
shares, shall be adjusted in proportion to the change in outstanding shares of Common Stock. In the event of any such adjustments, the
purchase price of any option, the performance objectives of any Incentive, and the shares of Common Stock issuable pursuant to any Incentive
shall be adjusted as and to the extent appropriate, in the discretion of the Committee, to provide participants with the same relative
rights before and after such adjustment.

 

10.7       Incentive
Plans and Agreements. Except in the case of stock awards or cash awards, the terms of each Incentive shall be stated in a plan or
agreement approved by the Committee.

 

10.8       Withholding.

 

	 	(a)	The Company shall have the right to withhold from any payments made under the 2022 Plan or to collect as a condition of payment, any taxes required by law to be withheld. At any time when a participant is required to pay to the Company an amount required to be withheld under applicable income tax laws in connection with a distribution of Common Stock or upon exercise of an option or SAR, the participant may satisfy this obligation in whole or in part by electing (the “Election”) to have the Company withhold from the distribution shares of Common Stock having a value up to the minimum amount of withholding taxes required to be collected on the transaction. The value of the shares to be withheld shall be based on the Fair Market Value of the Common Stock on the date that the amount of tax to be withheld shall be determined (“Tax Date”).

 

	 	(b)	Each Election must be made prior to the Tax Date. The Committee may disapprove of any Election, may suspend or terminate the right to make Elections, or may provide with respect to any Incentive that the right to make Elections shall not apply to such Incentive. An Election is irrevocable.

 

10.9       No
Continued Employment, Engagement or Right to Corporate Assets. No participant under the 2022 Plan shall have any right, because of
his or her participation, to continue in the employ of the Company for any period of time or to any right to continue his or her present
or any other rate of compensation. Nothing contained in the 2022 Plan shall be construed as giving an employee, a consultant, such persons’
beneficiaries or any other person any equity or interests of any kind in the assets of the Company or creating a trust of any kind or
a fiduciary relationship of any kind between the Company and any such person.  

 

10.10     Amendment.
The Board may amend or discontinue the 2022 Plan or any participant’s Incentive agreement at any time. However, no such amendment
or discontinuance shall adversely change or impair, without the consent of the recipient, an Incentive previously granted. Further, no
such amendment shall, without approval of the shareholders of the Company, (a) change or expand the types of Incentives that may be granted
under the 2022 Plan, (b) change the class of persons eligible to receive Incentives under the 2022 Plan, or (c) materially increase the
benefits accruing to participants under the 2022 Plan.

 

10.11     Sale,
Merger, Exchange or Liquidation. Unless otherwise provided in the agreement for an Incentive, in the event of an acquisition of the
Company through the sale of substantially all of the Company’s assets or through a merger, exchange, reorganization or liquidation
of the Company or a similar event as determined by the Committee (collectively a “transaction”), the Committee shall be authorized,
in its sole discretion, to take any and all action it deems equitable under the circumstances, including but not limited to any one or
more of the following:

 

	 	(i)	providing that the 2022 Plan and all Incentives shall terminate and the holders of (i) all outstanding vested options shall receive, in lieu of any shares of Common Stock they would be entitled to receive under such options, such stock, securities or assets, including cash, as would have been paid to such participants if their options had been exercised and such participant had received Common Stock immediately prior to such transaction (with appropriate adjustment for the exercise price, if any), (ii) performance shares and/or SARs that entitle the participant to receive Common Stock shall receive, in lieu of any shares of Common Stock each participant was entitled to receive as of the date of the transaction pursuant to the terms of such Incentive, if any, such stock, securities or assets, including cash, as would have been paid to such participant if such Common Stock had been issued to and held by the participant immediately prior to such transaction, and (iii) any Incentive under this Agreement which does not entitle the participant to receive Common Stock shall be equitably treated as determined by the Committee.

 

  
     

     

    
	 	(ii)	providing that participants holding outstanding vested Common Stock based Incentives shall receive, with respect to each share of Common Stock issuable pursuant to such Incentives as of the effective date of any such transaction, at the determination of the Committee, cash, securities or other property, or any combination thereof, in an amount equal to the excess, if any, of the Fair Market Value of such Common Stock on a date within ten days prior to the effective date of such transaction over the option price or other amount owed by a participant, if any, and that such Incentives shall be cancelled, including the cancellation without consideration of all options that have an exercise price below the per share value of the consideration received by the Company in the transaction.

 

	 	(iii)	providing that the 2022 Plan (or replacement plan) shall continue with respect to Incentives not cancelled or terminated as of the effective date of such transaction and provide to participants holding such Incentives the right to earn their respective Incentives on a substantially equivalent basis (taking into account the transaction and the number of shares or other equity issued by such successor entity) with respect to the equity of the entity succeeding the Company by reason of such transaction.

 

	 	(iv)	providing that all unvested, unearned or restricted Incentives, including but not limited to restricted stock for which restrictions have not lapsed as of the effective date of such transaction, shall be void and deemed terminated, or, in the alternative, for the acceleration or waiver of any vesting, earning or restrictions on any Incentive.

 

The Board may restrict the
rights of participants or the applicability of this Section 10.11 to the extent necessary to comply with Section 16(b) of the Securities
Exchange Act of 1934, the Internal Revenue Code or any other applicable law or regulation. The grant of an Incentive award pursuant to
the 2021 Plan shall not limit in any way the right or power of the Company to make adjustments, reclassifications, reorganizations or
changes of its capital or business structure or to merge, exchange or consolidate or to dissolve, liquidate, sell or transfer all or any
part of its business or assets.  

 

10.12     Definition
of Fair Market Value. For purposes of this 2022 Plan, the “Fair Market Value” of a share of Common Stock at a specified
date shall, unless otherwise expressly provided in this 2022 Plan, be the amount which the Committee or the Board of Directors determines
in good faith to be 100% of the fair market value of such a share as of the date in question; provided, however, that notwithstanding
the foregoing, if such shares are listed on a U.S. securities exchange or are quoted on the Nasdaq National Market or Nasdaq Small-Cap
Market (“Nasdaq”), then Fair Market Value shall be determined by reference to the last sale price of a share of Common Stock
on such U.S. securities exchange or Nasdaq on the applicable date. If such U.S. securities exchange or Nasdaq is closed for trading on
such date, or if the Common Stock does not trade on such date, then the last sale price used shall be the one on the date the Common Stock
last traded on such U.S. securities exchange or Nasdaq.

 

10.13     Change
in Control.

 

	Upon a Change in Control, as defined in paragraph (i) and (ii) of this Section 10.13, any stock option or restricted stock award granted to any Participant under this 2022 Plan that would have become vested upon continued employment by the Participant shall immediately vest in full and become exercisable, notwithstanding any provision to the contrary of such award, and notwithstanding the discretion of the Committee pursuant to Section 10.11.

 

	 	For purposes of this Section 10.13, “Change in Control” means:

 

	 	(i)	The acquisition by any person, entity or “group”, within the meaning of Section 13(d) (3) or 14(d) (2) of the Securities Exchange Act of 1934 (the “Exchange Act”) (excluding, for this purpose, (A) the Company, or (B) any employee benefit plan of the Company or its subsidiaries which acquires beneficial ownership of voting securities of the Company) of 50% or more of either the then outstanding shares of common stock or the combined voting power of the Company’s then outstanding voting securities entitled to vote generally in the election of directors; or

 

	 	(ii)	Approval by the stockholders of the Company of (A) a reorganization, merger or consolidation, in each case, with respect to which persons who were the stockholders of the Company immediately prior to such reorganization, merger or consolidation do not, immediately thereafter, own more than 50% of the combined voting power of the reorganized, merged or consolidated company’s then outstanding voting securities entitled to vote generally in the election of directors of the reorganized, merged or consolidated company, or (B) a liquidation or dissolution of the Company or (C) the sale of all or substantially all of the assets of the Company.

 

  
     

     

    
10.14     Section
409A.  Notwithstanding any other provisions of the 2022 Plan or any Incentive award agreement, no Incentive shall be granted,
deferred, accelerated, extended, paid out, adjusted pursuant to Section 10.6, or otherwise modified under the 2022 Plan in a manner that
would result in the imposition of an additional tax under Section 409A of the Code upon a participant. In the event that it is reasonably
determined by the Committee that, as a result of Section 409A of the Code, payments in respect of any Incentive may not be made at the
time contemplated by the terms of the 2022 Plan or the relevant Incentive award agreement, without causing the participant to be subject
to taxation under Section 409A of the Code, then the Company will make such payment on the first day that would not result in the participant
incurring any tax liability under Section 409A of the Code.EX-10.1

 Exhibit 10.1 

CONSENT AND SECOND AMENDMENT TO LOAN AND SECURITY AGREEMENT 

THIS CONSENT AND SECOND AMENDMENT TO LOAN AND SECURITY AGREEMENT (this “Agreement”), dated as of November 1, 2022, is
entered into by and among OUSTER, INC., a Delaware corporation (“Borrower”), SENSE PHOTONICS, INC., a Delaware corporation (“Guarantor”), the several banks and other financial institutions or entities party hereto
(each a “Lender” and, collectively, “Lenders”) and HERCULES CAPITAL, INC., a Maryland corporation, in its capacity as administrative agent and collateral agent for itself and the Lenders (together with its
successors and assigns, in such capacity, the “Agent”). 
 A. Borrower, Guarantor, Lenders and Agent are parties to that
certain Loan and Security Agreement, dated as of April 29, 2022, as amended by that certain First Amendment to Loan and Security Agreement dated as of August 5, 2022 (as the same may be further amended, restated, supplemented or otherwise
modified from time to time prior to the date of this Agreement, the “Loan Agreement”). 
 B. Borrower has notified Agent
and the Lenders that Borrower has entered or will enter into that certain Agreement and Plan of Merger, dated on or about the date hereof substantially in the form of Exhibit A attached hereto (the “Merger Agreement”), by and
among Borrower, Oban Merger Sub, Inc., a Delaware corporation and a wholly owned Subsidiary of Borrower (“Merger Sub I”), Oban Merger Sub II LLC, a Delaware limited liability company and wholly owned Subsidiary of Borrower
(“Merger Sub II” and, together with Merger Sub I, “Merger Subs”), and Velodyne Lidar, Inc., a Delaware corporation (“Target”), in connection with the merger by Merger Sub I with and into the Target
(the “First Merger”), followed by the merger of Target with and into Merger Sub II as soon as practicable following the consummation of the First Merger (the “Second Merger”), in each case as set forth in, and
pursuant to the terms of, the Merger Agreement. The Merger Agreement, the consummation of the First Merger and the consummation of the Second Merger, collectively, being the “Merger Transaction”. 

C. Borrower has requested that Agent and the Lenders consent to the Merger Transaction and make certain other revisions to the Loan Agreement.
Although Agent and the Lenders are under no obligation to do so, they have agreed to such requests, subject to the terms and conditions hereof.  

SECTION 1 Definitions; Interpretation. 

(a) Terms Defined in Loan Agreement. All capitalized terms used in this Agreement (including in the recitals hereof) and not otherwise
defined herein shall have the meanings assigned to them in the Loan Agreement (as amended by this Agreement). 
 (b) Rules of
Construction. The rules of construction in Section 1.3 of the Loan Agreement shall be applicable to this Agreement and are incorporated herein by this reference. 

SECTION 2 Consent. 
 (a) Subject to the
terms of this Agreement and notwithstanding anything to the contrary in the Loan Agreement and any of the other Loan Documents, including, without limitation, with respect to any requirements or restrictions contained in Section 7.6
(Investments), Section 7.7 (Distributions; Investments), and Section 7.9 (Mergers and Consolidations) of the Loan Agreement, Agent and the Lenders hereby consent to Borrower’s entry into the Merger Agreement and consummation of the
Merger Transaction and the Borrower and Merger Subs performing their respective obligations thereunder. 

 (b) The consent set forth in this Section 2 of this Agreement is
effective for the purposes set forth herein and shall be limited precisely as written and shall not be deemed or otherwise construed to (a) be a consent to any amendment, waiver, forbearance or modification of any other term or condition of any Loan
Document or any transaction other than the Merger Transaction and as otherwise expressly contemplated by this Agreement; (b) prejudice any right or remedy which Agent or the Lenders may now have or may have in the future under or in connection
with any Loan Document; or (c) limit or impair Agent’s or any Lender’s right to demand strict performance of all terms and covenants of the Loan Agreement, as amended hereby, as of any date. 

SECTION 3 Amendments to Loan Agreement. 

(a) Upon satisfaction of the conditions set forth in Section 4 hereof, the Loan Agreement is hereby amended as
follows: 
 (i) New Definitions. The following definitions are added to Section 1.1 of the Loan Agreement in their proper
alphabetical order: 
 “Second Amendment Effective Date” means November 1, 2022. 

“Merger Effective Date” means the Effective Time, as such term is defined in that certain Agreement and Plan of Merger dated
on or about the Second Amendment Effective Date, by and among, Borrower, Oban Merger Sub, Inc., a Delaware corporation and wholly owned Subsidiary of Borrow, Oban Merger Sub II LLC, a Delaware limited liability company and wholly owned Subsidiary of
Borrower, and Velodyne Lidar, Inc., a Delaware corporation. 
 (ii) Financial Covenant. Section 7.19 of the Loan Agreement is
hereby amended in its entirety and replaced with the following: 
 7.19 Financial Covenant. 

(a) Prior to the Merger Effective Date, commencing with the quarter ending on June 30, 2023 and for each fiscal quarter
thereafter which is a Testing Period, Borrower shall achieve T12M Revenue as set forth in Schedule 7.19 as of the last day of such fiscal quarter. 

(b) Commencing on the Merger Effective Date and at all times thereafter, (i) the covenant in the foregoing clause
(a) shall not apply and (ii) the Borrower shall maintain Cash in Deposit Accounts with respect to which Agent has an Account Control Agreement in an aggregate amount greater than or equal to Sixty Million Dollars ($60,000,000). 

(iii) Compliance Certificate. Exhibit E of the Loan Agreement is hereby amended in its entirety and replaced with Exhibit E
attached hereto and incorporated herein. 
 (b) References Within Loan Agreement. Each reference in the Loan Agreement to “this
Agreement” and the words “hereof,” “herein,” “hereunder”, or words of like import, shall mean and be a reference to the Loan Agreement as amended by this Agreement. This Agreement shall be a Loan Document. 

  
 2 

 SECTION 4 Conditions of Effectiveness. The effectiveness of this Agreement (the
“Second Amendment Effective Date”) shall be subject to Agent’s receipt of the following documents, in form and substance satisfactory to Agent, or, as applicable, the following conditions being met: 

(a) this Agreement, executed by Agent, each Lender, Borrower and Guarantor; 

(b) Borrower shall have paid (i) all invoiced costs and expenses then due in accordance with Section 8(d) of
this Agreement, and (ii) all other fees, costs and expenses, if any, due and payable as of the date hereof under the Loan Agreement; and 

(c) on the Second Amendment Effective Date, immediately after giving effect to the amendment of the Loan Agreement contemplated hereby: 

(i) The representations and warranties contained in Section 6 of this Agreement shall be true and correct on and as
of the Second Amendment Effective Date as though made on and as of such date; and 
 (ii) There exist no Events of Default or events that
with the passage of time would result in an Event of Default. 
 SECTION 5 Conditions Subsequent. 

(a) (I) on or prior to the date which is 30 days after its formation, Merger Sub I and any other Subsidiary (other than an Excluded Subsidiary)
shall have delivered a Joinder Agreement to become a Borrower under the Loan Agreement and executed any and all documents necessary to perfect Agent’s security interest in the Collateral, including but not limited to any Control Agreements or
have been dissolved or merged into a Borrower and (II) on or prior to the date which is 30 days after the consummation of the Merger, Target and any other Subsidiary (other than an Excluded Subsidiary) shall have delivered a Joinder Agreement
to become a Borrower under the Loan Agreement and executed any and all documents necessary to perfect Agent’s security interest in the Collateral, including but not limited to any Control Agreements. 

(b) Promptly following the consummation of the Merger, Borrower shall deliver to Agent executed copies of all documents, instruments, and
agreements in connection with the Merger. 
 SECTION 6 Representations and Warranties. To induce Agent and Lenders to enter into this
Agreement, Borrower hereby confirms, as of the date hereof, (a) that the representations and warranties made by it in Section 5 of the Loan Agreement and in the other Loan Documents are true and correct in all material respects;
provided, however, that such materiality qualifier shall not be applicable to any representations and warranties that already are qualified or modified by materiality in the text thereof; provided, further, that to the extent
such representations and warranties by their terms expressly relate only to a prior date such representations and warranties shall be true and correct as of such prior date, and (a) that no Event of Default has occurred and is continuing;
(b) that there has not been and there does not exist a Material Adverse Effect; (c) Lenders have and shall continue to have valid, enforceable and perfected first-priority liens, subject only to Permitted Liens, on and security interests
in the Collateral and all other collateral heretofore granted by Borrower to Lenders, pursuant to the Loan Documents or otherwise granted to or held by Lenders; (d) the agreements and obligations of Borrower contained in the Loan Documents and
in this Agreement constitute the legal, valid and binding obligations of Borrower, enforceable against Borrower in accordance with their respective terms, except as the enforceability thereof may be limited by bankruptcy, insolvency or other similar
laws of general application affecting the enforcement of creditors’ rights or by the application of general principles of equity; and (e) the execution, delivery and performance of this Agreement by Borrower will not violate any law, rule,
regulation, order, contractual obligation or organizational document of Borrower and will not result in, or require, the creation or imposition of any lien, claim or encumbrance of any kind on any of its properties or revenues. For the purposes of
this Section 6, each reference in Section 5 of the Loan Agreement to “this Agreement,” and the words “hereof”, “herein”, “hereunder”, or words of like import in such Section,
shall mean and be a reference to the Loan Agreement as amended by this Agreement. 

  
 3 

 SECTION 7 Release. In consideration of the agreements of Agent and each Lender contained
herein and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, Borrower, on behalf of itself and its successors, assigns, and other legal representatives, hereby to the extent possible under
applicable law fully, absolutely, unconditionally and irrevocably releases, remises and forever discharges Agent and each Lender, and its successors and assigns, and its present and former shareholders, affiliates, subsidiaries, divisions,
predecessors, directors, officers, attorneys, employees, agents and other representatives (Agent, Lenders and all such other persons being hereinafter referred to collectively as the “Releasees” and individually as a
“Releasee”), of and from all demands, actions, causes of action, suits, covenants, contracts, controversies, agreements, promises, sums of money, accounts, bills, reckonings, damages and any and all other claims, counterclaims,
defenses, rights of set-off, demands and liabilities whatsoever of every name and nature, known or unknown, suspected or unsuspected, both at law and in equity, which Borrower, or any of its successors,
assigns, or other legal representatives may now or hereafter own, hold, have or claim to have against the Releasees or any of them for, upon, or by reason of any circumstance, action, cause or thing whatsoever which arises at any time on or prior to
the day and date of this Agreement, for or on account of, or in relation to, or in any way in connection with the Loan Agreement, or any of the other Loan Documents or transactions thereunder or related thereto. Borrower understands, acknowledges
and agrees that the release set forth above may be pleaded as a full and complete defense and may be used as a basis for an injunction against any action, suit or other proceeding which may be instituted, prosecuted or attempted in breach of the
provisions of such release. Borrower agrees that no fact, event, circumstance, evidence or transaction which could now be asserted or which may hereafter be discovered shall affect in any manner the final, absolute and unconditional nature of the
release set forth above. 
 SECTION 8 Miscellaneous. 

(a) Loan Documents Otherwise Not Affected; Reaffirmation; No Novation. 

(i) Except as expressly amended pursuant hereto or referenced herein, the Loan Agreement and the other Loan Documents shall remain unchanged
and in full force and effect and are hereby ratified and confirmed in all respects. The Lenders’ and Agent’s execution and delivery of, or acceptance of, this Agreement shall not be deemed to create a course of dealing or otherwise create
any express or implied duty by any of them to provide any other or further amendments, consents or waivers in the future. 
 (ii) Borrower
hereby expressly (1) reaffirms, ratifies and confirms its Secured Obligations under the Loan Agreement and the other Loan Documents, (2) reaffirms, ratifies and confirms the grant of security under Section 3 of the Loan Agreement,
(3) reaffirms that such grant of security in the Collateral secures all Secured Obligations under the Loan Agreement, including without limitation any Term Loan Advances funded on or after the Second Amendment Effective Date, as of the date
hereof, and with effect from (and including) the Second Amendment Effective Date, such grant of security in the Collateral: (x) remains in full force and effect notwithstanding the amendments expressly referenced herein; and (y) secures
all Secured Obligations under the Loan Agreement, as amended by this Agreement, and the other Loan Documents, (4) agrees that this Agreement shall be a “Loan Document” under the Loan Agreement, and (5) agrees that the Loan
Agreement and each other Loan Document shall remain in full force and effect following any action contemplated in connection herewith. 

  
 4 

 (iii) This Agreement is not a novation and the terms and conditions of this Agreement shall
be in addition to and supplemental to all terms and conditions set forth in the Loan Documents. Nothing in this Agreement is intended, or shall be construed, to constitute an accord and satisfaction of Borrower’s Secured Obligations under or in
connection with the Loan Agreement and any other Loan Document or to modify, affect or impair the perfection or continuity of Agent’s security interest in, (on behalf of itself and the Lenders) security titles to or other liens on any
Collateral for the Secured Obligations. 
 (b) Conditions. For purposes of determining compliance with the conditions specified in
Section 4 of this Agreement, each Lender that has signed this Agreement shall be deemed to have consented to, approved or accepted or to be satisfied with, each document or other matter required thereunder to be consented
to or approved by or acceptable or satisfactory to the Lenders unless Agent shall have received notice from such Lender prior to the date hereof specifying its objection thereto. 

(c) No Reliance. Borrower hereby acknowledges and confirms to Agent and Lenders that Borrower is executing this Agreement on the basis
of its own investigation and for its own reasons without reliance upon any agreement, representation, understanding or communication by or on behalf of any other Person. 

(d) Costs and Expenses. Borrower agrees to pay to Agent on the date hereof the out-of-pocket costs and expenses of Agent and each Lender party hereto, and the fees and disbursements of counsel to Agent and each Lender party hereto (including allocated costs of internal counsel) in
connection with the negotiation, preparation, execution and delivery of this Agreement and any other documents to be delivered in connection herewith on the date hereof. 

(e) Binding Effect. This Agreement binds and is for the benefit of the successors and permitted assigns of each party. 

(f) Governing Law. THIS AGREEMENT AND THE OTHER LOAN DOCUMENTS SHALL BE GOVERNED BY, AND CONSTRUED AND ENFORCED IN ACCORDANCE WITH, THE
LAWS OF THE STATE OF CALIFORNIA, EXCLUDING CONFLICT OF LAWS PRINCIPLES THAT WOULD CAUSE THE APPLICATION OF LAWS OF ANY OTHER JURISDICTION. 

(g) Complete Agreement; Amendments. This Agreement and the Loan Documents represent the entire agreement about this subject matter and
supersede prior negotiations or agreements with respect to such subject matter. All prior agreements, understandings, representations, warranties, and negotiations between the parties about the subject matter of this Agreement and the Loan Documents
merge into this Agreement and the Loan Documents. 
 (h) Severability of Provisions. Each provision of this Agreement is severable
from every other provision in determining the enforceability of any provision. 
 (i) Counterparts. This Agreement may be executed in
any number of counterparts and by different parties on separate counterparts, each of which, when executed and delivered, is an original, and all taken together, constitute one Agreement. Delivery of an executed counterpart of a signature page of
this Agreement by facsimile, portable document format (.pdf) or other electronic transmission will be as effective as delivery of a manually executed counterpart hereof. 

(j) Electronic Execution of Certain Other Documents. The words “execution,” “execute”, “signed,”
“signature,” and words of like import in or related to any document to be signed in connection with this Agreement and the transactions contemplated hereby (including without limitation assignments, assumptions, amendments, waivers and
consents) shall be deemed to include electronic signatures, the electronic matching of assignment terms and contract formations on electronic platforms approved by the Agent, or the keeping of records in electronic form, each of which shall be of
the same legal effect, validity 

  
 5 

 
or enforceability as a manually executed signature or the use of a paper-based recordkeeping system, as the case may be, to the extent and as provided for in any applicable law, including the
Federal Electronic Signatures in Global and National Commerce Act, the California Uniform Electronic Transactions Act, or any other similar state laws based on the Uniform Electronic Transactions Act. 

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK] 

  
 6 

 IN WITNESS WHEREOF, the parties hereto have duly executed this Agreement, as of the date
first above written. 
  

			
	BORROWER:
	
	OUSTER, INC.
		
	Signature:	 	 /s/ Charles Angus Pacala

	Print Name:	 	Charles Angus Pacala
	Title:	 	Chief Executive Officer
	
	GUARANTOR:
	
	SENSE PHOTONICS, INC.
		
	Signature:	 	 /s/ Charles Angus Pacala

	Print Name:	 	Charles Angus Pacala
	Title:	 	Chief Executive Officer

 [SIGNATURES CONTINUE ON THE NEXT PAGE] 

 
			
	AGENT:
	HERCULES CAPITAL, INC.
		
	By:	 	 /s/ Seth Meyer

	Name:	 	Seth Meyer
	Title:	 	Chief Financial Officer

 
			
	LENDERS:
	
	HERCULES CAPITAL, INC.
		
	By:	 	 /s/ Seth Meyer

	Name:	 	Seth Meyer
	Title:	 	Chief Financial Officer
	
	 HERCULES PRIVATE GLOBAL

VENTURE GROWTH FUND I L.P.

	
	By: Hercules Adviser LLC, its Investment Adviser
		
	By:	 	 /s/ Seth Meyer

	Name:	 	Seth Meyer
	Title:	 	Authorized Signatory

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00350-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00350-of-00352.parquet"}]]